2023. Deletion of sphingosine kinase 2 attenuates cigarette smoke-mediated chronic obstructive pulmonary disease-like symptoms by reducing lung inflammation. Biomolecules and Biomedicine. 23, 2 (Mar. 2023), 259–270. DOI:https://doi.org/10.17305/bjbms.2022.8034.